ScripWith biopharma investors eager for hard numbers on the impact of the Trump administration’s tariff policy on corporate financials, Merck & Co. CEO Robert Davis offered some answers on 24 April, sa
ScripLike a number of big pharma players, Sanofi is investing heavily in expanding its production footprint in the US but chief financial officer François Roger has talked up the importance of Europe to th
Pink SheetThe European Medicines Agency has started reviewing for potential pan-EU marketing authorization 15 new drugs, including Novo Nordisk’s semaglutide for the treatment of non-cirrhotic metabolic dysfunc
Pink SheetThe heads of two of Europe’s largest pharma companies urged the EU to increase drug prices to be more in line with the US, a move unlikely to be greeted enthusiastically in the cash-strapped continent